May 13, 2020 / 5:11 AM / 12 days ago

BRIEF-Sprint Bioscience Announces Identity Of Target Protein In Project VADA

May 13 (Reuters) - Sprint Bioscience AB:

* ANNOUNCES THE IDENTITY OF THE TARGET PROTEIN IN THE WHOLLY-OWNED PROJECT VADA

* GOAL IS TO DEVELOP DRUG SUBSTANCES THAT INHIBIT PROTEIN VACCINIA-RELATED KINASE 1 (VRK1) IN ORDER TO ENHANCE EFFECTS OF IMMUNO-ONCOLOGY THERAPY, RADIATION THERAPY AND CHEMOTHERAPY Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below